OTCMKTS:CRLBF Cresco Labs (CRLBF) Stock Price, News & Analysis → Does this make you sick? (From Allegiance Gold) (Ad) Free CRLBF Stock Alerts $2.13 -0.03 (-1.39%) (As of 05/20/2024 ET) Add Compare Share Share Today's Range$2.07▼$2.2550-Day Range$1.52▼$2.4852-Week Range$1.00▼$2.77Volume564,781 shsAverage Volume1.23 million shsMarket Capitalization$736.17 millionP/E RatioN/ADividend YieldN/APrice Target$16.00 Stock AnalysisStock AnalysisAnalyst ForecastsChartEarningsFinancialsHeadlinesSEC FilingsShort InterestStock AnalysisAnalyst ForecastsChartEarningsFinancialsHeadlinesSEC FilingsShort Interest Get Cresco Labs alerts: Email Address Cresco Labs MarketRank™ Stock AnalysisAnalyst RatingModerate Buy2.60 Rating ScoreUpside/Downside651.2% Upside$16.00 Price TargetShort InterestHealthy0.52% of Shares Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.70Based on 32 Articles This WeekInsider TradingN/AProj. Earnings GrowthGrowingFrom ($0.05) to ($0.02) Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.1.65 out of 5 stars 3.3 Analyst's Opinion Consensus RatingCresco Labs has received a consensus rating of Moderate Buy. The company's average rating score is 2.60, and is based on 3 buy ratings, 2 hold ratings, and no sell ratings.Amount of Analyst CoverageCresco Labs has only been the subject of 4 research reports in the past 90 days.Read more about Cresco Labs' stock forecast and price target. Previous Next 3.0 Short Interest Percentage of Shares Shorted0.52% of the outstanding shares of Cresco Labs have been sold short.Short Interest Ratio / Days to CoverCresco Labs has a short interest ratio ("days to cover") of 0.8, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Cresco Labs has recently increased by 0.46%, indicating that investor sentiment is decreasing. Previous Next 0.0 Dividend Strength Dividend YieldCresco Labs does not currently pay a dividend.Dividend GrowthCresco Labs does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for CRLBF. Previous Next 2.6 News and Social Media Coverage News SentimentCresco Labs has a news sentiment score of 0.70. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.43 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 32 news articles for Cresco Labs this week, compared to 2 articles on an average week.Search InterestOnly 8 people have searched for CRLBF on MarketBeat in the last 30 days. This is a decrease of -20% compared to the previous 30 days.MarketBeat FollowsOnly 3 people have added Cresco Labs to their MarketBeat watchlist in the last 30 days. This is a decrease of -83% compared to the previous 30 days. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Cresco Labs insiders have not sold or bought any company stock.Percentage Held by InstitutionsOnly 0.05% of the stock of Cresco Labs is held by institutions.Read more about Cresco Labs' insider trading history. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for Cresco Labs are expected to grow in the coming year, from ($0.05) to ($0.02) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Cresco Labs is -4.53, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Cresco Labs is -4.53, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioCresco Labs has a P/B Ratio of 1.72. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about Cresco Labs' valuation and earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad Allegiance GoldDoes this make you sick?The US Dollar Is "Finished" A deteriorating economy, global instability, and a weakened banking system have pushed the U.S. financial system to the brink, imperiling the value of your savings and investments.Get your Free Wealth Protection Kit About Cresco Labs Stock (OTCMKTS:CRLBF)Cresco Labs Inc., together with its subsidiaries, cultivates, manufactures, and sells retail and medical cannabis products in the United States. It provides cannabis in flowers, vape pens, live resins, disposable pens, and extracts under the Cresco brand; vape carts, vape pens, flower, popcorn, shake, pre-rolls, shorties, and concentrates under the High Supply brand; vapes and gummies under the Good News brand; vapes and edibles under the Wonder Wellness Co. brand; and tinctures, capsules, salves, and sublingual oils under the Remedi brand. The company also offers cannabis flowers under the FloraCal brand; and chocolate and toffee confections and fruit-forward gummies under the Mindy's Edibles brand, as well as licenses the Kiva brand, which produces cannabis infused edibles, including chocolate confections, gummies, mints, and tarts. In addition, the company offers cannabis-infused edibles under the Sunnyside brand. The company was incorporated in 1990 and is headquartered in Chicago, Illinois.Read More CRLBF Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart CRLBF Stock News HeadlinesMay 20 at 4:12 AM | americanbankingnews.comCresco Labs Inc. (OTCMKTS:CRLBF) to Post FY2025 Earnings of $0.02 Per Share, Roth Capital ForecastsMay 20 at 2:50 AM | americanbankingnews.comCresco Labs Inc. Expected to Post FY2024 Earnings of ($0.09) Per Share (OTCMKTS:CRLBF)May 20 at 1:38 AM | americanbankingnews.comQ2 2024 EPS Estimates for Cresco Labs Inc. (OTCMKTS:CRLBF) Boosted by Alliance Global PartnersMay 20 at 1:38 AM | americanbankingnews.comQ2 2024 EPS Estimates for Cresco Labs Inc. Raised by Echelon Wealth Partners (OTCMKTS:CRLBF)May 20 at 1:38 AM | americanbankingnews.comQ2 2024 Earnings Estimate for Cresco Labs Inc. (OTCMKTS:CRLBF) Issued By WedbushMay 19 at 3:30 AM | americanbankingnews.comCresco Labs Inc. (OTCMKTS:CRLBF) Expected to Post FY2025 Earnings of ($0.07) Per ShareMay 18 at 4:38 AM | americanbankingnews.comCresco Labs (OTCMKTS:CRLBF) PT Raised to $3.00 at WedbushMay 18 at 4:38 AM | americanbankingnews.comCresco Labs (OTCMKTS:CRLBF) Stock Rating Reaffirmed by Needham & Company LLCMay 16, 2024 | finance.yahoo.comCresco Labs Inc (CRLBF) Q1 2024 Earnings Call Transcript Highlights: Strategic Growth Amidst ...May 15, 2024 | finance.yahoo.comCresco Labs Reports Continued Trend of Financial Improvement with First Quarter 2024 Financial ResultsMay 15, 2024 | americanbankingnews.comCresco Labs (OTCMKTS:CRLBF) Stock Price Up 0.5%May 9, 2024 | investorplace.comShhh! 3 Secret Penny Stocks Flying Below Wall Street's RadarMay 9, 2024 | finance.yahoo.comCresco Labs Announces May Conference ParticipationMay 8, 2024 | msn.comWill Cresco Labs Inc. (CRLBF) Report Negative Earnings Next Week? What You Should KnowMay 4, 2024 | investorplace.comWall Street Analysts Predict 1000% Upside for These 7 Penny StocksApril 30, 2024 | businesswire.comCresco Labs to Report First Quarter 2024 Financial Results on May 15, 2024April 23, 2024 | msn.comNANX Stock Earnings: Nanophase Technologies Reported Results for Q1 2024April 18, 2024 | benzinga.comCannabis Chart Of The Week: How Much Have MSO Valuation Multiples Changed In The Last Year And Why?April 17, 2024 | msn.comMarijuana banking unlikely to pass House due to Republican leadership spatApril 17, 2024 | fool.comThe Best Cannabis Stock to Invest $1,000 in Right NowApril 9, 2024 | markets.businessinsider.comJefferies Remains a Buy on Cresco Labs (CRLBF)March 28, 2024 | msn.com2 Marijuana Companies That Have Recently Turned ProfitsMarch 27, 2024 | investorplace.com3 Cannabis Stocks to Buy Before the Coming Pre-Election RallyMarch 20, 2024 | msn.comCresco vs. Tilray: Which Cannabis Stock Is a Better Buy?March 18, 2024 | investorplace.comCRLBF Stock Earnings: Cresco Labs Beats EPS, Beats Revenue for Q4 2023See More Headlines Receive CRLBF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Cresco Labs and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings5/15/2024Today5/21/2024Next Earnings (Estimated)5/22/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Medicinals & botanicals Sub-IndustryN/A Current SymbolOTCMKTS:CRLBF CUSIPN/A CIK1832928 Webwww.crescolabs.com Phone312-929-0993FaxN/AEmployees2,760Year FoundedN/APrice Target and Rating Average Stock Price Target$16.00 High Stock Price Target$34.00 Low Stock Price Target$2.00 Potential Upside/Downside+651.2%Consensus RatingModerate Buy Rating Score (0-4)2.60 Research Coverage5 Analysts Profitability EPS (Most Recent Fiscal Year)($0.47) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-175,520,000.00 Net Margins-20.32% Pretax Margin-19.06% Return on Equity-6.61% Return on Assets-2.17% Debt Debt-to-Equity Ratio1.55 Current Ratio1.39 Quick Ratio0.85 Sales & Book Value Annual Sales$770.89 million Price / Sales0.95 Cash Flow$0.05 per share Price / Cash Flow42.46 Book Value$1.24 per share Price / Book1.72Miscellaneous Outstanding Shares345,620,000Free FloatN/AMarket Cap$736.17 million OptionableNot Optionable Beta2.08 10 Best Stocks to Own in 2024Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2024 and why they should be in your portfolio. Get This Free Report Key ExecutivesMr. Charles Bachtell (Age 45)Co-Founder, CEO & Director Comp: $999.85kMr. Robert M. Sampson (Age 49)Co-Founder & Independent Director Mr. Dennis M. Olis (Age 61)Chief Financial Officer Comp: $622.85kMr. Gregory Butler (Age 43)President & Chief Transformation Officer Mr. Ty Gent (Age 65)Chief Operating Officer Mr. Zach Marburger (Age 39)Chief Information Officer Ms. Megan KulickSenior Vice President of Investor RelationsMr. John Schetz (Age 46)General Counsel Mr. Jason Erkes (Age 53)Chief Communications Officer Ms. Angie Demchenko (Age 43)Chief People Officer More ExecutivesKey CompetitorsMind Medicine (MindMed)NASDAQ:MNMDUSANA Health SciencesNYSE:USNAbioteNASDAQ:BTMDCanopy GrowthNASDAQ:CGCAurora CannabisNASDAQ:ACBView All Competitors CRLBF Stock Analysis - Frequently Asked Questions Should I buy or sell Cresco Labs stock right now? 5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Cresco Labs in the last year. There are currently 2 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" CRLBF shares. View CRLBF analyst ratings or view top-rated stocks. What is Cresco Labs' stock price target for 2024? 5 Wall Street analysts have issued 12 month price targets for Cresco Labs' stock. Their CRLBF share price targets range from $2.00 to $34.00. On average, they anticipate the company's share price to reach $16.00 in the next twelve months. This suggests a possible upside of 651.2% from the stock's current price. View analysts price targets for CRLBF or view top-rated stocks among Wall Street analysts. How have CRLBF shares performed in 2024? Cresco Labs' stock was trading at $1.3558 at the beginning of 2024. Since then, CRLBF shares have increased by 57.1% and is now trading at $2.13. View the best growth stocks for 2024 here. When is Cresco Labs' next earnings date? The company is scheduled to release its next quarterly earnings announcement on Wednesday, May 22nd 2024. View our CRLBF earnings forecast. How were Cresco Labs' earnings last quarter? Cresco Labs Inc. (OTCMKTS:CRLBF) released its quarterly earnings data on Wednesday, May, 15th. The company reported ($0.02) EPS for the quarter, meeting analysts' consensus estimates of ($0.02). The company earned $184.30 million during the quarter, compared to analysts' expectations of $183.31 million. Cresco Labs had a negative net margin of 20.32% and a negative trailing twelve-month return on equity of 6.61%. How do I buy shares of Cresco Labs? Shares of CRLBF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:CRLBF) was last updated on 5/21/2024 by MarketBeat.com Staff From Our PartnersNext President (Not Trump. Not Biden.)The Freeport SocietyConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsDoes this make you sick?Allegiance Gold[FREE Ticket] 27 Crypto Experts Reveal Their #1 Picks Crypto 101 Media4 Cryptos BETTER than BitcoinTrue Market InsidersBill Gates is all about this tiny $2 stockTimothy SykesThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldDid You Get Your Free Bitcoin Yet?Crypto Swap Profits Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cresco Labs Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.